DK2714042T3 - En analgetisk farmaceutisk sammensætning til oral administration - Google Patents

En analgetisk farmaceutisk sammensætning til oral administration

Info

Publication number
DK2714042T3
DK2714042T3 DK12735347.2T DK12735347T DK2714042T3 DK 2714042 T3 DK2714042 T3 DK 2714042T3 DK 12735347 T DK12735347 T DK 12735347T DK 2714042 T3 DK2714042 T3 DK 2714042T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
oral administration
analgesic pharmaceutical
analgesic
oral
Prior art date
Application number
DK12735347.2T
Other languages
English (en)
Inventor
Magdalena Bujalska-Zad-Rozny
Marek Naruszewicz
Original Assignee
Univ Warszawski Medyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Warszawski Medyczny filed Critical Univ Warszawski Medyczny
Application granted granted Critical
Publication of DK2714042T3 publication Critical patent/DK2714042T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK12735347.2T 2011-05-31 2012-05-31 En analgetisk farmaceutisk sammensætning til oral administration DK2714042T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL39506911A PL395069A1 (pl) 2011-05-31 2011-05-31 Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego
PCT/PL2012/050016 WO2012165985A1 (en) 2011-05-31 2012-05-31 An analgesic pharmaceutical composition for oral administration

Publications (1)

Publication Number Publication Date
DK2714042T3 true DK2714042T3 (da) 2019-01-02

Family

ID=46513810

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12735347.2T DK2714042T3 (da) 2011-05-31 2012-05-31 En analgetisk farmaceutisk sammensætning til oral administration

Country Status (7)

Country Link
US (1) US9101577B2 (da)
EP (1) EP2714042B1 (da)
DK (1) DK2714042T3 (da)
ES (1) ES2708689T3 (da)
HU (1) HUE040419T2 (da)
PL (2) PL395069A1 (da)
WO (1) WO2012165985A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014237237A1 (en) * 2013-03-15 2015-10-29 Russell Jaffe Soft gel encapsulation
GB2607333A (en) * 2021-06-03 2022-12-07 Horopito Ltd Pain relief composition
EP4389120A1 (en) * 2022-12-20 2024-06-26 Inflacod Sp. z o.o. An anti-inflammatory pharmaceutical composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2116257T3 (da) * 2000-08-09 2013-02-04 Alk Abello As Parenterale vaccineformuleringer og anvendelser deraf
IL159156A0 (en) * 2001-06-22 2004-06-01 Millard Marsden Mershon A gel forming composition containing a polyacrylic acid
RU2284189C2 (ru) * 2001-08-27 2006-09-27 Киова Кемикал Индастри Ко., Лтд. Антацидная и слабительная таблетка
US20040048870A1 (en) * 2002-09-06 2004-03-11 Amir Ahmad A. Composition for the prevention and treatment of migraine headaches
JP2006522819A (ja) * 2003-04-08 2006-10-05 プロジェニックス ファーマシューティカルズ,インコーポレーテッド 緩下薬および末梢オピオイドアンタゴニストを組み合わせた便秘の組み合わせ療法
US20070259033A1 (en) * 2003-09-26 2007-11-08 Evangeline Cruz Controlled release formulations exhibiting an ascending rate of release
US20080220064A1 (en) * 2006-12-06 2008-09-11 Ramesh Ketkar Anant Extended release matrix formulations of morphine

Also Published As

Publication number Publication date
ES2708689T3 (es) 2019-04-10
EP2714042A1 (en) 2014-04-09
HUE040419T2 (hu) 2019-03-28
WO2012165985A1 (en) 2012-12-06
PL2714042T3 (pl) 2019-03-29
US20140127302A1 (en) 2014-05-08
US9101577B2 (en) 2015-08-11
EP2714042B1 (en) 2018-08-29
PL395069A1 (pl) 2012-12-03

Similar Documents

Publication Publication Date Title
SMT201500232B (it) Dispositivo per la somministrazione de farmaci
DK2680832T3 (da) Vandig farmaceutisk formulering af tapentadol til oral administration
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
CO6852076A2 (es) Composiciones farmacéuticas inhalables
DK3527241T3 (da) Indretning til administration af lægemiddel
DK2694038T3 (da) Farmaceutisk sammensætning
BR112013017169A2 (pt) composições farmacêuticas de ferro para administração oral
BR112014003052A2 (pt) composições farmacêuticas
DK3284467T3 (da) Nikotinholdige farmaceutiske sammensætninger
DK3246018T3 (da) Farmaceutisk sammensætning
EP2629786A4 (en) COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS
CO6930367A2 (es) Composiciones farmaceúticas
SMT201600341B (it) Soluzione per somministrazione orale
EE201300005A (et) Ravimkoostis
BR112013012476A2 (pt) formulações farmacêuticas contendo corticosteróides para administração tópica
CO6940426A2 (es) Formulaciones farmacéuticas
DK2815752T3 (da) Oral farmaceutisk sammensætning
BRPI1007484A2 (pt) composição farmacêutica para administração oral
BR112014009889A2 (pt) compostos dissubstituídos, compostos e composição farmacêutica
EP2731605A4 (en) PHARMACEUTICAL COMPOSITIONS FOR RECTAL ADMINISTRATION
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
SMT201500005B (it) Composizione framaceutica inalabile
CU24163B1 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
BR112014015885A2 (pt) preparação farmacêutica
EP2668852A4 (en) COMPOSITION FOR ORAL ADMINISTRATION